You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Amiloride Hydrochloride And Hydrochlorothiazide, and when can generic versions of Amiloride Hydrochloride And Hydrochlorothiazide launch?

Amiloride Hydrochloride And Hydrochlorothiazide is a drug marketed by Barr, Chartwell Rx, Rising, Teva, and Watson Labs. and is included in five NDAs.

The generic ingredient in AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Amiloride Hydrochloride And Hydrochlorothiazide

A generic version of AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE was approved as amiloride hydrochloride; hydrochlorothiazide by BARR on May 10th, 1988.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
  • What are the global sales for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
  • What is Average Wholesale Price for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
Summary for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Instituto de Cardiologia do Rio Grande do SulPhase 3
Hospital de Clinicas de Porto AlegrePhase 3
Guangdong Provincial People's HospitalPhase 4

See all AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE amiloride hydrochloride; hydrochlorothiazide TABLET;ORAL 071111-001 May 10, 1988 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE amiloride hydrochloride; hydrochlorothiazide TABLET;ORAL 070795-001 Apr 17, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE amiloride hydrochloride; hydrochlorothiazide TABLET;ORAL 073357-001 Nov 27, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE amiloride hydrochloride; hydrochlorothiazide TABLET;ORAL 073209-001 Oct 31, 1991 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE amiloride hydrochloride; hydrochlorothiazide TABLET;ORAL 073334-001 Jul 19, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.